Women's Attractiveness Changes with Estradiol and Progesterone Across the Ovulatory Cycle
Overview
Psychology
Social Sciences
Authors
Affiliations
In many species, females are more sexually attractive to males near ovulation. Some evidence suggests a similar pattern in humans, but methodological limitations prohibit firm conclusions at present, and information on physiological mechanisms underlying any such pattern is lacking. In 202 normally-cycling women, we explored whether women's attractiveness changed over the cycle as a function of two likely candidates for mediating these changes: estradiol and progesterone. We scheduled women to attend one session during the late follicular phase and another during the mid-luteal phase. At each session, facial photographs, voice recordings and saliva samples were collected. All photographs and voice recordings were subsequently rated by men for attractiveness and by women for flirtatiousness and attractiveness to men. Saliva samples were assayed for estradiol and progesterone. We found that progesterone and its interaction with estradiol negatively predicted vocal attractiveness and overall (facial plus vocal) attractiveness to men. Progesterone also negatively predicted women's facial attractiveness to men and female-rated facial attractiveness, facial flirtatiousness and vocal attractiveness, but not female-rated vocal flirtatiousness. These results strongly suggest a pattern of increased attractiveness during peak fertility in the menstrual cycle and implicate estradiol and progesterone in driving these changes.
Chemosensory Cues Modulate Women's Jealousy Responses to Vocal Femininity.
Han C, Lei X, Wei R, Nan Y, Gan J, Morrison E Arch Sex Behav. 2025; .
PMID: 39806190 DOI: 10.1007/s10508-024-03081-3.
Lobmaier J, Klatt W, Schweinberger S Front Psychol. 2024; 15:1401158.
PMID: 39734777 PMC: 11671799. DOI: 10.3389/fpsyg.2024.1401158.
Ejaculate Adjustment in Response to Sperm Competition Risk in Humans.
DeLecce T, Vance G, Zeigler-Hill V, Welling L, Shackelford T Arch Sex Behav. 2024; 54(1):277-287.
PMID: 39500803 DOI: 10.1007/s10508-024-03030-0.
Challenges of prescribing testosterone for sexual dysfunction in women: Number 7 - 2024.
Lara L, Pereira J, de Paula S, de Oliveira F, Cunha A, Lerner T Rev Bras Ginecol Obstet. 2024; 46.
PMID: 39176198 PMC: 11341187. DOI: 10.61622/rbgo/2024FPS07.
Zetzsche M, Weiss B, Kucklich M, Stern J, Birkemeyer C, Widdig A Proc Biol Sci. 2024; 291(2027):20232712.
PMID: 39043247 PMC: 11265918. DOI: 10.1098/rspb.2023.2712.